Capricor Therapeutics | CAPR - Current Liabilities


Capricor Therapeutics reported $32.96M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Bioline Rx USD 13.68M 55K Jun/2026
Capricor Therapeutics USD 32.96M 676K Jun/2026
Cipla INR 69.77B 366.6M Sep/2026
Cytokinetics USD 353.42M 171.99M Sep/2026
Geron USD 74.25M 3.92M Sep/2026
Grifols EUR 2.37B 156.97M Dec/2025
Immunic USD 38.36M 7.74M Mar/2026
J&J USD 55.46B 562M Sep/2026
Plus Therapeutics USD 8.57M 612K Jun/2026
Prothena USD 11.43M 224K Sep/2026
PTC Therapeutics USD 776.08M 5.01M Sep/2026
Sarepta Therapeutics USD 656.35M 153.44M Sep/2026